NL-OMON20862招募中不适用
A prospective trial with ketoconazole and octreotide combination therapy for treatment of Cushing’s disease.
Erasmus MC Rotterdam0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 10
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Both naïve patients with Cushing’s disease and patients with residual hypercortisolism
- •after recent transsphenoidal adenomectomy are eligible for enrolment. Finally, patients
- •with recurrent Cushing’s disease can also be included.
排除标准
- •1. Patients with a disturbed liver function indicated by serum bilirubin, ALAT, ASAT or alkaline phosphatase levels > 2.5 x ULN;
- •2. Patients with renal insufficiency indicated by serum creatinine levels > 2.0 x ULN;
研究者
相似试验
进行中（未招募）
不适用
A study with ketoconazole and octreotide combination therapy for treatment of Cushing’s disease.Cushing's disease (which is caused by an ACTH producing pituitary adenoma)MedDRA version: 14.0Level: LLTClassification code 10011651Term: Cushing's diseaseSystem Organ Class: 10014698 - Endocrine disordersEUCTR2011-003264-77-NLErasmus MC
已完成
2 期
A prospective trial with ketoconazole and octreotide combination therapy for treatment of Cushing*s disease.Cushing's diseasepituitary ACTH hypersecretion10021112NL-OMON36055Erasmus MC, Universitair Medisch Centrum Rotterdam10
进行中（未招募）
不适用
Ketoconazole in Locally Advanced or Disseminated Granulosa Cell Tumour of Ovary.EUCTR2012-001948-21-ESGrupo Español de Tumores Huérfanos e Infrecuentes
已完成
1 期
Influence of Ketoconazole on the Pharmacokinetics of Romidepsin in Patients With Advanced CancerHematologic MalignancyMalignant LymphomaNCT01324310Celgene15
已完成
3 期
Evaluation of the effectiveness of climbazole shampoo treatment.tinea versicolor.Pityriasis versicolorB36.0IRCT20190811044510N1Kerman University of Medical Sciences60